DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

PRI-724

Generic Name: PRI-724

Drug Type: Small Molecule

Chemical Formula: C_₃₃H_₃₅N_₆O_₇P

CAS Number: 1198780-38-9

Unique Ingredient Identifier: 43Y934BBZ6

Overview

PRI-724 is under investigation in clinical trial NCT03620474 (Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis).

Background

PRI-724 is under investigation in clinical trial NCT03620474 (Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis

Phase 1

Completed

Posted: 2018/08/08

Sponsor:

Kiminori Kimura, MD

A Follow-up Evaluation Study of PRI-724-1101

Completed

Posted: 2016/07/11

Sponsor:

Komagome Hospital

Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer

Phase 2

Withdrawn

Posted: 2015/04/10

Sponsor:University of Southe...

An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis

Phase 1

Completed

Posted: 2014/07/21

Sponsor:

Komagome Hospital

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Phase 1

Completed

Posted: 2013/01/09

Sponsor:Prism Pharma Co., Lt...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy